Article info
PDFOriginal research
Research abuses against people of colour and other vulnerable groups in early psychedelic research
- Correspondence to Ms Dana Strauss, Psychology, University of Ottawa, Ottawa, Canada; dana.strauss{at}uottawa.ca
Citation
Research abuses against people of colour and other vulnerable groups in early psychedelic research
Publication history
- Received January 21, 2021
- Accepted June 13, 2021
- First published July 12, 2021.
Online issue publication
September 28, 2022
Article Versions
- Previous version (12 July 2021).
- Previous version (15 September 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Psychedelic crossings: American mental health and LSD in the 1970s
- Psychedelic injustice: should bioethics tune in to the voices of psychedelic-using communities?
- Ethics and ego dissolution: the case of psilocybin
- Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
- Pineal gland as the source of the soul and third eye
- Chronic pain and psychedelics: a review and proposed mechanism of action
- Supple bodies, healthy minds: yoga, psychedelics and American mental health
- Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
- R & D for LSD?
- Psilocybin: a revolution in psychedelic medicines in the US?